Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sandesh Seth currently holds 184,481 shares of Actinium Pharmaceuticals, Inc. (ATNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandesh Seth has been a net buyer of ATNM stock. They have purchased $148.2K and sold $0 worth of shares.
Sandesh Seth's most recent insider trade was on Aug 18, 2025, when they sold 120,900 shares at $1.71 per share.
Sandesh Seth serves as Executive at Actinium Pharmaceuticals, Inc. (ATNM). They have executed 30 insider transactions totaling $148.2K over their tenure at the company.
Sandesh Seth holds the position of Executive at Actinium Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Sandesh Seth has shown a buying trading pattern, with $148.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Sandesh Seth was on Aug 18, 2025, when they sold $206.7K worth of ATNM shares. This transaction involved 120,900 shares at $1.71 per share.
Sandesh Seth currently owns 184,481 shares of Actinium Pharmaceuticals, Inc. (ATNM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sandesh Seth's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sandesh Seth has 30 Form 4 filings on record as an insider at Actinium Pharmaceuticals, Inc..
Set alerts for Sandesh Seth and 40,000+ other insiders.